CIK 0001681682 · Non-accelerated filer<br>Smaller reporting company
ENDRA Life Sciences Inc.
Sign in to watch- Ticker
- NDRA
- Exchange
- Nasdaq
- Industry
- Electromedical & Electrotherapeutic Apparatus
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 260579295
- Phone
- 734-335-0468
- Business address
- 3600 GREEN COURT, SUITE 350, ANN ARBOR, MI, 48105
- Former names
- Endra Inc.
- 8-K Event Exit or restructuring costs · Regulation FD disclosure
- 4 Grant or award Chief Executive Officer acquired 26,921 shares (grant or award)
- 4 Grant or award Chief Financial Officer acquired 13,461 shares (grant or award)
- 4 Grant or award Director acquired 60,324 shares (grant or award)
- 4 Grant or award Director acquired 60,324 shares (grant or award)
- 4 Grant or award Chief Financial Officer acquired 20,000 shares (grant or award)
- 4 Grant or award Director acquired 60,324 shares (grant or award)
- 4 Grant or award Chief Executive Officer acquired 75,000 shares (grant or award)
- 8-K Event Executive or director change · Bylaws or fiscal year change · Shareholder vote results
- 8-K Event Executive or director change
- SCHEDULE 13D Stake Beneficial Ownership Report
- 424B4 Offering Prospectus
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- 8-K Event Other events
- 10-Q Report Quarterly Report
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- S-3 Offering Registration Statement
- SCHEDULE 13G Stake Statement of Beneficial Ownership
- 8-K Event Material agreement
- 424B5 Offering Prospectus
Page 3 of 28 · 547 filings